Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00698035 · BASELINE

Baseline characteristics

Vaginal Testosterone Cream vs ESTRING for Vaginal Dryness or Decreased Libido in Early Stage Breast Cancer Patients · Source last updated 2014-06-02

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms
  1. counts
    1. group Id
      BG000
      value
      39
    2. group Id
      BG001
      value
      36
    3. group Id
      BG002
      value
      75
    units
    Participants
groups
  1. description
    Estring 2mg ring inserted vaginally once every 12 weeks
    id
    BG000
    title
    Estring
  2. description
    Testosterone Cream 1% micronized in velvachol - 0.5 gm of cream vaginally each night for two weeks, then 3 times a week for total of 12 weeks of treatment
    id
    BG001
    title
    Testosterone Cream
  3. description
    Total of all reporting groups
    id
    BG002
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          lower Limit
          37
          upper Limit
          78
          value
          56
        2. group Id
          BG001
          lower Limit
          38
          upper Limit
          74
          value
          57
        3. group Id
          BG002
          lower Limit
          37
          upper Limit
          78
          value
          56
    dispersion Type
    FULL_RANGE
    param Type
    MEAN
    title
    Age, Continuous
    unit Of Measure
    years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          39
        2. group Id
          BG001
          value
          36
        3. group Id
          BG002
          value
          75
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          0
        2. group Id
          BG001
          value
          0
        3. group Id
          BG002
          value
          0
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          39
        2. group Id
          BG001
          value
          36
        3. group Id
          BG002
          value
          75
      title
      United States
    param Type
    NUMBER
    title
    Region of Enrollment
    unit Of Measure
    participants
population Description
Baseline Characteristics for 75 participants who initiated treatment. One participant consented and was assigned to ESTRING, but did not insert ESTRING prior to withdrawing from the study.
Complete source fields
denoms
  1. counts
    1. group Id
      BG000
      value
      39
    2. group Id
      BG001
      value
      36
    3. group Id
      BG002
      value
      75
    units
    Participants
groups
  1. description
    Estring 2mg ring inserted vaginally once every 12 weeks
    id
    BG000
    title
    Estring
  2. description
    Testosterone Cream 1% micronized in velvachol - 0.5 gm of cream vaginally each night for two weeks, then 3 times a week for total of 12 weeks of treatment
    id
    BG001
    title
    Testosterone Cream
  3. description
    Total of all reporting groups
    id
    BG002
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          lower Limit
          37
          upper Limit
          78
          value
          56
        2. group Id
          BG001
          lower Limit
          38
          upper Limit
          74
          value
          57
        3. group Id
          BG002
          lower Limit
          37
          upper Limit
          78
          value
          56
    dispersion Type
    FULL_RANGE
    param Type
    MEAN
    title
    Age, Continuous
    unit Of Measure
    years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          39
        2. group Id
          BG001
          value
          36
        3. group Id
          BG002
          value
          75
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          0
        2. group Id
          BG001
          value
          0
        3. group Id
          BG002
          value
          0
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          39
        2. group Id
          BG001
          value
          36
        3. group Id
          BG002
          value
          75
      title
      United States
    param Type
    NUMBER
    title
    Region of Enrollment
    unit Of Measure
    participants
population Description
Baseline Characteristics for 75 participants who initiated treatment. One participant consented and was assigned to ESTRING, but did not insert ESTRING prior to withdrawing from the study.

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice